Philips publishes its Annual Report 2025
Rhea-AI Summary
Royal Philips (NYSE: PHG) published its Annual Report 2025 on February 19, 2026. The report has been filed with the Netherlands Authority for the Financial Markets in ESEF and is expected to be filed on Form 20-F with the SEC later today.
The Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders on May 8, 2026. The report (ESEF and Form 20-F) is available at www.results.philips.com, and printed copies can be requested via annual.report@philips.com. Investor and media contacts are provided for further information.
Positive
- None.
Negative
- None.
News Market Reaction – PHG
On the day this news was published, PHG declined 1.84%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
February 19, 2026
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025.
Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course.
Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to file the report on Form 20-F with the U.S. Securities and Exchange Commission later today (www.sec.gov).
The Annual Report 2025 (in ESEF and on Form 20-F) is available to shareholders and other interested parties at www.results.philips.com. A printed copy can be obtained free of charge upon written request to the following email address: annual.report@philips.com.
For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 614 869 261
E-mail: michael.fuchs@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 205 977 055
E-mail: dorin.danu@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Forward-looking statements and other information
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
FAQ
When will Philips (PHG) discuss the Annual Report 2025 at its AGM?
Where can investors access Philips (PHG) Annual Report 2025 online?
Has Philips (PHG) filed the Annual Report 2025 with regulators?
How can I request a printed copy of Philips (PHG) Annual Report 2025?
Who can investors contact for more information about Philips (PHG) Annual Report 2025?
